New York 2023-2024 Regular Session

New York Assembly Bill A01022

Introduced
1/13/23  
Refer
1/13/23  

Caption

Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.

Companion Bills

No companion bills found.

Previously Filed As

NY A07746

Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.

NY S07562

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY HB562

Relating to warning labels for opioid prescription drugs.

NY S08285

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

NY A05852

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

NY HB972

Relating to warning labels for opioid prescription drugs.

NY HB816

Relating to warning labels for opioid prescription drugs.

NY S07508

Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.

NY SB1986

Relating to warning labels for opioid prescription drugs.

NY HB847

Relating to warning labels for opioid prescription drugs.

Similar Bills

No similar bills found.